Concomitant presence of JAK2 V617F mutation and BCR-ABL translocation in a pregnant woman with polycythemia vera

Medical Oncology

Volumn 28, Issue 4, 2011, Pages 1555-1558

  Toogeh, Gholamreza ^a   Ferdowsi, Shirin ^a   Naadali, Fatemeh ^b   Alimoghaddam, Kamran ^c   Ghavamzadeh, Ardeshir ^c   Shirkoohi, Reza ^a   Ghaffari, Seyed H ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

BCR ABL translocation; JAK2V617F mutation; Polycythemia vera; Pregnancy

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; HYDROXYUREA; JANUS KINASE 2;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; LABORATORY TEST; POLYCYTHEMIA VERA; PREGNANT WOMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; FEMALE; FUSION PROTEINS, BCR-ABL; GENES, ABL; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; JANUS KINASE 2; MUTATION; POLYCYTHEMIA VERA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 84655176810     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9570-8     Document Type: Article

References (50)

1. EJ Baxter 2005 Acquired mutation of thetyrosine kinase JAK2 in human myeloproliferative disorders Lancet 365 1054 1061
2. RL Levine 2005 Activating mutation in thetyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis Cancer Cell 7 387 397
3. A Tefferi 2007 JAK2 mutations in polycythemia vera-molecular mechanisms and clinical applications New Eng J Med 356 444 445
4. N Cambier 2008 JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders Leukemia 22 1454 1455
5. I Mirza C Frantz G Clarke A Voth R Turner 2007 Transformation of polycythemia vera to chronic myelogenous leukemia Arch Pathol Lab Med 131 1719 1724
6. CB Ping GG Gan VS Nadarajan NA Latiff N Menaka 2010 A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders Int J Hematol 91 136 139
7. S Pingali M Mathiason S Lovrich S Ronald 2009 Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocation Clin Lymphoma Myeloma 9 25 29
8. AL Centrone RN Freda L McGowan 1967 Polycythemia rubra vera in pregnancy Obstet Gynecol 30 657 659
9. RE Harris FG Conrad 1967 Polycythemia vera in the childbearing age Arch Intern Med 120 697 700
10. O Pata 2004 Polycythemia vera and pregnancy: a case report with the use of hydroxyurea in the first trimester Am J Perinatol 21 135 137
11. A Hochman JA Stein 1961 Polycythemia and pregnancy. Report of a case Obstet Gynecol 18 230 235
12. JE Ferguson 2nd K Ueland WJ Aronson 1983 Polycythemia rubra vera and pregnancy Obstet Gynecol 62 16s 20s
13. AV Jones 2005 Widespread occurrence of the JAK2V617F mutation in chronic myeloproliferative disorders Blood 106 2162 2168
14. M Yaghmaie 2008 Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia Arch Iran Med 11 247 251
15. A Tefferi LA Solberg MN Silverstein 2000 A clinical up date in polycythemia vera and essential thrombocythemia Am J Med 109 141 149
16. C James 2006 Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis Leukemia 20 350 353
17. A Saviola 2005 Transition of polycythemia vera to chronic myeloid leukaemia Eur J Haematol 75 264 266
18. E Jantunen T Nousiainen 1991 Ph-positive chronic myelogenous leukemia evolving after polycythemiavera Am J Hematol 37 212
19. EC Hoppin JP Lewis 1975 Polycythemia rubra vera progressing to Ph-positive chronic myelogenous leukemia Ann Intern Med 83 820 823
20. AU Haq 1990 Transformation of polycythemia vera to Ph-positive chronic myelogenous leukemia Am J Hematol 35 110 113
21. E Mercier G Lissalde-Lavigne J Gris 2007 JAK2 V617F mutation in unexplained loss of first pregnancy N Engl J Med 19 357
22. I Plo 2008 JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders Blood 112 1402 1412
23. S Xie 2001 Involvement of Jak2 tyrosine phosphorylation in bcrabl transformation Oncogene 20 6188 6195
24. CM Morris 1998 Essential thrombocythemia and the Philadelphia chromosome Br J Haematol 70 13 17
25. P Martiat 1989 Molecular analysis of Philadelphia positive essential thrombocythemia Leukemia 3 563 568
26. R Sarode N Marwaha RK Gupta G Garewal 1989 Philadelphia chromosome in essential thrombocythaemia? (letter) Am J Hematol 30 45
27. DB Stoll 1998 Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome Am J Hematol 27 77 83
28. D Blickstein 1997 BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients: clinical presentation Blood 90 2768 2771
29. HC Hsu 2004 Detrction of bcr-abl gene expression at a low level in blood cells of some patients with essential thrombocythemia J Lab Clin Med 143 125 129
30. YL Kwong EK Chiu RH Liang V Chan TK Chan 1996 Essential thrombocythemia with BCR/ABL rearrangement Cancer Genet Cytogenet 89 74 76
31. A Aviram 1999 Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients Leuk Lymphoma. 33 77 82
32. NJ Curtin PJ Campbell AR Green 2005 The Philadelphia translocation and pre-existing myeloproliferative disorders Br J Haematol 128 734 736
33. M Bornhaüser 2007 Concurrent JAK2 (V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis Leukemia 21 1824 1826
34. K Hussein 2007 Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation Blood 109 4106 4107
35. M Griesshammer S Struve CM Harrison 2006 Essential thrombocythemia/ polycythemia vera and pregnancy: the need for an observational study in Europe Semin Thromb Hemost 32 422 429
36. S Robinson S Bewley B Hunt D Radia C Harrison 2005 The management and outcome of 18 pregnancies in women with polycythemia vera Haematologica 90 1477 1483
37. F Passamonti 2007 Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V-F) mutation Blood 110 485 489
38. CA Wright A Tefferi 2001 A single institutional experience with 43 pregnancies in essential thrombocythemia Eur J Haematol 66 152 159
39. M Bangerter 2000 Pregnancy in essential thrombocythaemia: treatment and outcome of 17 pregnancies Eur J Haematol 65 165 169
40. M Celiloglu S Altnyurt B Undar 2000 Hydroxyurea treatment for chronic myeloid leukemia during pregnancy Acta Obstet Gyne Scand 79 803 804
41. SA Fadilah H Ahmad-Zailani C Soon-Keng M Norlaila 2002 Successful treatment of chronic myeloid leukemia during pregnancy with hydroxyurea Leukemia 16 1202 1203
42. C Thauvin-Robinet 2001 Exposure to hydroxyurea during pregnancy: a case series Leukemia 15 1309 1311
43. C Baykal N Zengin F Coskun N Guler A Ayhan 2000 Use of hydroxyurea and alpha-interferon in chronic myeloid leukemia during pregnancy: a case report Eur J Gynaecol Oncol 21 89 99
44. N Vianelli 1994 Interferon-a2a treatment in a pregnant woman with essential thrombocythaemia Blood 83 874 875
45. S Thornley A Manoharan 1994 Successful treatment of essential thrombocythaemia with alpha interferon during pregnancy Eur J Haematol 52 63 64
46. JM Williams PE Schlesinger AG Gray 1994 Successful treatment of essential thrombocythaemia and recurrent abortion with alpha interferon Br J Haematol 88 647 648
47. R Delage C Demers G Cantin J Roy 1996 Treatment of essential thrombocythemia during pregnancy with interferon alpha Obstet Gynecol 87 814 817
48. V Milano 1996 Successful treatment of essential thrombocythemia in a pregnancy with recombinant interferon-alpha 2a J Matern Fetal Med 5 74 78
49. S Pardini 1993 Alpha 2b-interferon therapy and pregnancy: report of a case of essential thrombocythaemia Am J Hematol 43 78 79
50. J Kiladjian 2008 Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera Blood 112 3065 3072